Results 161 to 170 of about 188,451 (293)

Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells. [PDF]

BMC Cancer, 2023
Okabe S, Gotoh A.
europepmc   +1 more source

Omacetaxine: A Protein Translation Inhibitor for Treatment of Chronic Myelogenous Leukemia

Clinical Cancer Research, 2014
V. Gandhi, W. Plunkett, J. Cortes
semanticscholar   +1 more source

Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells. [PDF]

Biomedicines, 2023
Basappa B, Jung YY, Ravish A, Xi Z, Swamynayaka A, Madegowda M, Pandey V, Lobie PE, Sethi G, Ahn KS.   +9 more
europepmc   +1 more source

A Phase III Multi-center, Open-label, Randomized Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Novartis
openalex   +1 more source

Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides [PDF]

, 1992
Mariusz Z. Ratajczak, Nobuko Hijiya, Lucia Catani, K DeRiel, S. M. Luger, P. B. Mcglave, AM Gewirtz   +6 more
openalex   +1 more source

NADPH Oxidases as Therapeutic Targets in Chronic Myelogenous Leukemia

Clinical Cancer Research, 2014
B. Sánchez-Sánchez, Sara Gutiérrez-Herrero, Guillermo López-Ruano, Rodrigo Prieto-Bermejo, Marta Romo-González, M. Llanillo, A. Pandiella, C. Guerrero, J. Miguel, F. Sanchez-Guijo, C. del Cañizo, Á. Hernández-Hernández   +11 more
semanticscholar   +1 more source

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

Blood, 1990
H. J. Kolb, J. Mittermuller, Ch. Clemm, E. Holler, G. Ledderose, G. Brehm, M. Heim, W. Wilmanns   +7 more
semanticscholar   +2 more sources

Inhibition of autophagy enhances the sensitivity of ciclopirox olamine in human chronic myelogenous leukemia K562 cells. [PDF]

Int J Med Sci
Zhou H, Chen H, Luo K, Kong L, Li Y.
europepmc   +1 more source

AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects. [PDF]

Cell Death Discov, 2023
Gayatri MB, Kancha RK, Behera A, Patchva D, Velugonda N, Gundeti S, Reddy ABM.   +6 more
europepmc   +1 more source

Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia [PDF]

, 2011
Mio Yamamoto‐Sugitani, Junya Kuroda, Eishi Ashihara, Hisao Nagoshi, Tsutomu Kobayashi, Yosuke Matsumoto, Nana Sasaki, Yuji Shimura, Miki Kiyota, Ryuko Nakayama, Kenichi Akaji, Tomohiko Taki, Nobuhiko Uoshima, Yutaka Kobayashi, Shigeo Horiike, Taira Maekawa, Masafumi Taniwaki   +16 more
openalex   +1 more source